SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme reports Profit after tax of Rs 203.17 Mln, in the December 2020 quarter

12 Feb 2021 Evaluate
A decent increase of about 28.66% in the sales to Rs. 791.45 millions was observed for the quarter ended December 2020. The sales figure stood at Rs. 615.13 millions during the year-ago period.A slim rise of 15.92% was recorded in the Net profit for the quarter ended December 2020 to Rs. 203.17  millions  From Rs. 175.27 millions.OP of the company witnessed a marginal growth to 286.59 millions from 242.70 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202012 201912 % Var 202012 201912 % Var 202003 201903 % Var
Sales 791.45 615.13 28.66 2128.65 1789.34 18.96 2473.54 2220.93 11.37
Other Income 17.74 49.69 -64.30 42.39 77.12 -45.03 90.01 56.10 60.45
PBIDT 286.59 242.70 18.08 829.32 615.45 34.75 857.67 579.94 47.89
Interest 0.15 2.35 -93.62 0.75 7.33 -89.77 11.00 22.27 -50.61
PBDT 286.44 240.35 19.18 828.57 608.12 36.25 846.67 557.67 51.82
Depreciation 22.24 22.37 -0.58 64.97 65.61 -0.98 88.14 85.63 2.93
PBT 264.20 217.98 21.20 763.60 542.51 40.75 758.53 472.04 60.69
TAX 61.03 42.71 42.89 205.88 123.01 67.37 178.98 119.70 49.52
Deferred Tax 9.58 -3.67 -361.04 12.24 -8.27 -248.00 -14.91 0.06 -24950.00
PAT 203.17 175.27 15.92 557.72 419.50 32.95 579.55 352.34 64.49
Equity 223.45 223.35 0.04 223.45 223.35 0.04 223.36 223.30 0.03
PBIDTM(%) 36.21 39.46 -8.22 38.96 34.40 13.27 34.67 26.11 32.79

Advanced Enzyme Share Price

299.15 0.30 (0.10%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×